Assessing Severity and Biologic Barriers in Hidradenitis Suppurativa
A Dermatology Times case discussion examines how clinicians stage hidradenitis suppurativa severity and why barriers often delay access to biologic therapy for eligible patients.
Topic
Adalimumab
Topic